Cargando…

Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design

Inhibition of the protein-protein interaction (PPI) mediated by breast-cancer-gene 1 C-terminal (BRCT) is an attractive strategy to sensitize breast and ovarian cancers to chemotherapeutic agents that induce DNA damage. Such inhibitors could also be used for studies to understand the role of this PP...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Wanli, Huang, Yu-ming M., Kizhake, Smitha, Natarajan, Amarnath, Chang, Chia-en A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999267/
https://www.ncbi.nlm.nih.gov/pubmed/27560145
http://dx.doi.org/10.1371/journal.pcbi.1005057
_version_ 1782450091502600192
author You, Wanli
Huang, Yu-ming M.
Kizhake, Smitha
Natarajan, Amarnath
Chang, Chia-en A.
author_facet You, Wanli
Huang, Yu-ming M.
Kizhake, Smitha
Natarajan, Amarnath
Chang, Chia-en A.
author_sort You, Wanli
collection PubMed
description Inhibition of the protein-protein interaction (PPI) mediated by breast-cancer-gene 1 C-terminal (BRCT) is an attractive strategy to sensitize breast and ovarian cancers to chemotherapeutic agents that induce DNA damage. Such inhibitors could also be used for studies to understand the role of this PPI in DNA damage response. However, design of BRCT inhibitors is challenging because of the inherent flexibility associated with this domain. Several studies identified short phosphopeptides as tight BRCT binders. Here we investigated the thermodynamic properties of 18 phosphopeptides or peptide with phosphate mimic and three compounds with phosphate groups binding to BRCT to understand promiscuous molecular recognition and guide inhibitor design. We performed molecular dynamics (MD) simulations to investigate the interactions between inhibitors and BRCT and their dynamic behavior in the free and bound states. MD simulations revealed the key role of loops in altering the shape and size of the binding site to fit various ligands. The mining minima (M2) method was used for calculating binding free energy to explore the driving forces and the fine balance between configuration entropy loss and enthalpy gain. We designed a rigidified ligand, which showed unfavorable experimental binding affinity due to weakened enthalpy. This was because it lacked the ability to rearrange itself upon binding. Investigation of another phosphate group containing compound, C1, suggested that the entropy loss can be reduced by preventing significant narrowing of the energy well and introducing multiple new compound conformations in the bound states. From our computations, we designed an analog of C1 that introduced new intermolecular interactions to strengthen attractions while maintaining small entropic penalty. This study shows that flexible compounds do not always encounter larger entropy penalty, compared with other more rigid binders, and highlights a new strategy for inhibitor design.
format Online
Article
Text
id pubmed-4999267
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49992672016-09-12 Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design You, Wanli Huang, Yu-ming M. Kizhake, Smitha Natarajan, Amarnath Chang, Chia-en A. PLoS Comput Biol Research Article Inhibition of the protein-protein interaction (PPI) mediated by breast-cancer-gene 1 C-terminal (BRCT) is an attractive strategy to sensitize breast and ovarian cancers to chemotherapeutic agents that induce DNA damage. Such inhibitors could also be used for studies to understand the role of this PPI in DNA damage response. However, design of BRCT inhibitors is challenging because of the inherent flexibility associated with this domain. Several studies identified short phosphopeptides as tight BRCT binders. Here we investigated the thermodynamic properties of 18 phosphopeptides or peptide with phosphate mimic and three compounds with phosphate groups binding to BRCT to understand promiscuous molecular recognition and guide inhibitor design. We performed molecular dynamics (MD) simulations to investigate the interactions between inhibitors and BRCT and their dynamic behavior in the free and bound states. MD simulations revealed the key role of loops in altering the shape and size of the binding site to fit various ligands. The mining minima (M2) method was used for calculating binding free energy to explore the driving forces and the fine balance between configuration entropy loss and enthalpy gain. We designed a rigidified ligand, which showed unfavorable experimental binding affinity due to weakened enthalpy. This was because it lacked the ability to rearrange itself upon binding. Investigation of another phosphate group containing compound, C1, suggested that the entropy loss can be reduced by preventing significant narrowing of the energy well and introducing multiple new compound conformations in the bound states. From our computations, we designed an analog of C1 that introduced new intermolecular interactions to strengthen attractions while maintaining small entropic penalty. This study shows that flexible compounds do not always encounter larger entropy penalty, compared with other more rigid binders, and highlights a new strategy for inhibitor design. Public Library of Science 2016-08-25 /pmc/articles/PMC4999267/ /pubmed/27560145 http://dx.doi.org/10.1371/journal.pcbi.1005057 Text en © 2016 You et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
You, Wanli
Huang, Yu-ming M.
Kizhake, Smitha
Natarajan, Amarnath
Chang, Chia-en A.
Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design
title Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design
title_full Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design
title_fullStr Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design
title_full_unstemmed Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design
title_short Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design
title_sort characterization of promiscuous binding of phosphor ligands to breast-cancer-gene 1 (brca1) c-terminal (brct): molecular dynamics, free energy, entropy and inhibitor design
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999267/
https://www.ncbi.nlm.nih.gov/pubmed/27560145
http://dx.doi.org/10.1371/journal.pcbi.1005057
work_keys_str_mv AT youwanli characterizationofpromiscuousbindingofphosphorligandstobreastcancergene1brca1cterminalbrctmoleculardynamicsfreeenergyentropyandinhibitordesign
AT huangyumingm characterizationofpromiscuousbindingofphosphorligandstobreastcancergene1brca1cterminalbrctmoleculardynamicsfreeenergyentropyandinhibitordesign
AT kizhakesmitha characterizationofpromiscuousbindingofphosphorligandstobreastcancergene1brca1cterminalbrctmoleculardynamicsfreeenergyentropyandinhibitordesign
AT natarajanamarnath characterizationofpromiscuousbindingofphosphorligandstobreastcancergene1brca1cterminalbrctmoleculardynamicsfreeenergyentropyandinhibitordesign
AT changchiaena characterizationofpromiscuousbindingofphosphorligandstobreastcancergene1brca1cterminalbrctmoleculardynamicsfreeenergyentropyandinhibitordesign